This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies
by Zacks Equity Research
Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies are part of the Zacks top Analyst Blog.
Top Research Reports for Novo Nordisk, AstraZeneca & Accenture
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AstraZeneca PLC (AZN) and Accenture plc (ACN).
Here's Why You Should Give Roper (ROP) Stock a Shot Now
by Zacks Equity Research
Roper (ROP) is poised for growth on the back of strength across all its segments, acquired assets and portfolio restructuring initiatives. The company's efforts to add shareholder value hold promise.
Is WisdomTree U.S. Multifactor ETF (USMF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for USMF
Roper Technologies (ROP) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Roper Technologies (ROP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Roper (ROP) Rewards Shareholders With 10% Dividend Hike
by Zacks Equity Research
Roper's (ROP) dividend increase for 30 consecutive years is supported by its strong free cash flow generation capacity.
Roper (ROP) Beats on Q3 Earnings, Improves 2022 Outlook
by Zacks Equity Research
Roper's (ROP) Q3 results benefit from strength in its segments. Owing to strong performance, the company raises its full-year earnings guidance.
Roper Technologies (ROP) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Roper Technologies (ROP) delivered earnings and revenue surprises of 6.69% and 1.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Roper (ROP) Disappoint in Q3 Earnings on Cost Woes?
by Zacks Equity Research
Increasing cost of sales are likely to have hurt Roper's (ROP) Q3 earnings. However, the top line is expected to have benefited from strong segmental performances.
Strength Seen in Nutanix (NTNX): Can Its 24.6% Jump Turn into More Strength?
by Zacks Equity Research
Nutanix (NTNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Roper (ROP) Closes Frontline Education Acquisition Deal
by Zacks Equity Research
Roper's (ROP) acquisition of Frontline Education expands its presence in the K-12 education market. The company's successive acquisitions should foster its top-line growth.
Reasons Why You Should Avoid Investing in Roper (ROP) Now
by Zacks Equity Research
Roper (ROP) experiences softness due to supply-chain bottlenecks. Also, operating cost inflation and unfavorable foreign-currency movements are added concerns.
Is WisdomTree U.S. Multifactor ETF (USMF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for USMF
Roper (ROP) Inks $3.73B Deal to Acquire Frontline Education
by Zacks Equity Research
Roper's (ROP) impeding acquisition of Frontline Education builds on its Horizon software business, expanding its presence in the K-12 education market.
Roper (ROP) Beats on Q2 Earnings, Improves 2022 Outlook
by Zacks Equity Research
Roper's (ROP) Q2 results benefit from software recurring revenue growth. Owing to strong performance, the company raises its full-year earnings guidance.
Roper Technologies (ROP) Tops Q2 Earnings Estimates
by Zacks Equity Research
Roper Technologies (ROP) delivered earnings and revenue surprises of 3.40% and 14.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ServiceNow (NOW) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
ServiceNow (NOW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Roper Technologies (ROP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Roper Technologies (ROP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Offing for Roper (ROP) This Earnings Season?
by Zacks Equity Research
While impressive performances of the Application Software and Network Software segments are likely to have aided Roper's (ROP) Q2 earnings, high costs might have partly hurt performance.
Middleby (MIDD) Acquires Proxaut, Boosts Product Portfolio (Revised)
by Zacks Equity Research
The acquisition of Proxaut will enable Middleby (MIDD) to strengthen its product menu in the food processing end market.
Middleby (MIDD) Acquires Proxaut, Boosts Product Portfolio
by Zacks Equity Research
The acquisition of Proxaut will enable Middleby (MIDD) to strengthen its product menu in the food processing end market.
Crane (CR) Displays Bright Prospects, Headwinds Persist
by Zacks Equity Research
Crane (CR) stands to gain from its end-market strength, divestments and shareholder-friendly policies. However, cost woes and supply-chain issues pose a concern.
Stanley Black (SWK) Inks Deal to Divest Oil & Gas Business
by Zacks Equity Research
Stanley Black's (SWK) sale of the oil & gas division will help it concentrate on and proficiently channelize its resources to its Industrial and Tools & Outdoor segments.
MRC Global (MRC) Displays Bright Prospects, Risks Persist
by Zacks Equity Research
MRC Global (MRC) stands to benefit from strength across its end markets, lucrative contracts and shareholder-friendly policies. However, cost woes and supply-chain issues weigh on it.
Enerpac (EPAC) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Enerpac's (EPAC) third-quarter fiscal 2022 revenues increase 6.1% year over year on account of solid performance across the Industrial Tools & Services segment.